Mohamad AF, Warman NAE, Zainordin NA, Awang MH, Shah FZM, Ghani RA. RISK OF KETOACIDOSIS WITH LUSEOGLIFLOZIN IN TYPE 2 DIABETES MELLITUS PATIENTS ON MODERATE DOSE INSULIN THERAPY: A RANDOMISED CONTROL TRIAL. J ASEAN Fed Endocr Soc [Internet]. 2024 Jul. 17 [cited 2024 Oct. 1];39(S1):34-5. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/4489